{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T23:38:22Z","timestamp":1783726702014,"version":"3.55.0"},"reference-count":24,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.7863\/jum.2012.31.3.463","type":"journal-article","created":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T19:28:46Z","timestamp":1483990126000},"page":"463-468","source":"Crossref","is-referenced-by-count":9,"title":["Cerebral Blood Flow in Patients With Fabry Disease as Measured by Doppler Sonography Is Not Different From That in Healthy Individuals and Is Unaffected by Treatment"],"prefix":"10.7863","volume":"31","author":[{"given":"Nurcan","family":"\u00dc\u00e7eyler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Kathrin","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Breunig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"M\u00fcllges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,3,1]]},"reference":[{"key":"10.7863\/jum.2012.31.3.463-BIB0001|jum2012313463-cit-0001","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pharmthera.2009.01.003","article-title":"Fabry disease","volume":"122","author":"Schiffmann","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.7863\/jum.2012.31.3.463-BIB0002|jum2012313463-cit-0002","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.ATV.0000209649.60409.38","article-title":"Cardiac and vascular hypertrophy in Fabry disease: evidence for a new mechanism independent of blood pressure and glycosphingolipid deposition","volume":"26","author":"Barbey","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.7863\/jum.2012.31.3.463-BIB0003|jum2012313463-cit-0003","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","article-title":"Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy","volume":"138","author":"Desnick","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.7863\/jum.2012.31.3.463-BIB0004|jum2012313463-cit-0004","first-page":"615218","article-title":"Fabry disease and early stroke","volume":"2011","author":"Feldt-Rasmussen","year":"2011","journal-title":"Stroke Res Treat"},{"key":"10.7863\/jum.2012.31.3.463-BIB0005|jum2012313463-cit-0005","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1212\/01.wnl.0000173030.70057.eb","article-title":"White matter lesion severity in male and female patients with Fabry disease","volume":"65","author":"Fellgiebel","year":"2005","journal-title":"Neurology"},{"key":"10.7863\/jum.2012.31.3.463-BIB0006|jum2012313463-cit-0006","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.brainresbull.2003.09.021","article-title":"White matter lesions in Fabry disease occur in \u201cprior\u201d selectively hypometabolic and hyperperfused brain regions","volume":"62","author":"Moore","year":"2003","journal-title":"Brain Res Bull"},{"key":"10.7863\/jum.2012.31.3.463-BIB0007|jum2012313463-cit-0007","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/STROKEAHA.108.526293","article-title":"Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry Registry","volume":"40","author":"Sims","year":"2009","journal-title":"Stroke"},{"key":"10.7863\/jum.2012.31.3.463-BIB0008|jum2012313463-cit-0008","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s00415-004-0364-9","article-title":"Reduced cerebral blood flow velocity and impaired cerebral autoregulation in patients with Fabry disease","volume":"251","author":"Hilz","year":"2004","journal-title":"J Neurol"},{"key":"10.7863\/jum.2012.31.3.463-BIB0009|jum2012313463-cit-0009","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/hs0202.102601","article-title":"Elevated cerebral blood flow velocities in Fabry disease with reversal after enzyme replacement","volume":"33","author":"Moore","year":"2002","journal-title":"Stroke"},{"key":"10.7863\/jum.2012.31.3.463-BIB0010|jum2012313463-cit-0010","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1529-8027.2011.00365.x","article-title":"Small fibers in Fabry disease: baseline and follow-up data under enzyme replacement therapy","volume":"16","author":"\u00dc\u00e7eyler","year":"2011","journal-title":"J Peripher Nerve Syst"},{"key":"10.7863\/jum.2012.31.3.463-BIB0011|jum2012313463-cit-0011","volume-title":"Transcranial Doppler","author":"Newell","year":"1992"},{"key":"10.7863\/jum.2012.31.3.463-BIB0012|jum2012313463-cit-0012","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0090-3019(87)90149-2","article-title":"Transcranial Doppler ultrasound for the assessment of intracranial arterial flow velocity, part 2: evaluation of intracranial arterial disease","volume":"27","author":"Hennerici","year":"1987","journal-title":"Surg Neurol"},{"key":"10.7863\/jum.2012.31.3.463-BIB0013|jum2012313463-cit-0013","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-18585-4","volume-title":"Doppler und Duplex Sonographie der Hirnversorgenden Arterien","author":"Widder","year":"2004"},{"key":"10.7863\/jum.2012.31.3.463-BIB0014|jum2012313463-cit-0014","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1093\/ndt\/gfp031","article-title":"Fabry disease: progression of nephropathy and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy","volume":"24","author":"Schiffmann","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.7863\/jum.2012.31.3.463-BIB0015|jum2012313463-cit-0015","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1681\/ASN.2006121400","article-title":"Antiproteinuric therapy and Fabry nephropathy: sustained reduction of proteinuria in patients receiving enzyme replacement therapy with agalsidase-beta","volume":"18","author":"Tahir","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.7863\/jum.2012.31.3.463-BIB0016|jum2012313463-cit-0016","doi-asserted-by":"crossref","first-page":"e598","DOI":"10.1371\/journal.pone.0000598","article-title":"Treatment of Fabry disease: outcome of a comparative trial with agalsidase alfa or beta at a dose of 0.2 mg\/kg","volume":"2","author":"Vedder","year":"2007","journal-title":"PLoS One"},{"key":"10.7863\/jum.2012.31.3.463-BIB0017|jum2012313463-cit-0017","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ymgme.2009.10.004","article-title":"Vasculopathy in patients with Fabry disease: current controversies and research directions","volume":"99","author":"Rombach","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.7863\/jum.2012.31.3.463-BIB0018|jum2012313463-cit-0018","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/08035320600618924","article-title":"Increased carotid intima-media thickness in the absence of atherosclerotic plaques in an adult population with Fabry disease","volume":"95","author":"Barbey","year":"2006","journal-title":"Acta Paediatr Suppl"},{"key":"10.7863\/jum.2012.31.3.463-BIB0019|jum2012313463-cit-0019","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s10545-006-0340-x","article-title":"Structural and functional changes in peripheral vasculature of Fabry patients","volume":"29","author":"Kalliokoski","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"10.7863\/jum.2012.31.3.463-BIB0020|jum2012313463-cit-0020","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1161\/hc3801.096352","article-title":"Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapy","volume":"104","author":"Moore","year":"2001","journal-title":"Circulation"},{"key":"10.7863\/jum.2012.31.3.463-BIB0021|jum2012313463-cit-0021","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000322558","article-title":"Basilar artery diameter is a potential screening tool for Fabry disease in young stroke patients","volume":"31","author":"Fellgiebel","year":"2011","journal-title":"Cerebrovasc Dis"},{"key":"10.7863\/jum.2012.31.3.463-BIB0022|jum2012313463-cit-0022","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/brain\/awh546","article-title":"Megadolichobasilar anomaly with thrombosis in a family with Fabry's disease and a novel mutation in the alpha-galactosidase A gene","volume":"128","author":"Garzuly","year":"2005","journal-title":"Brain"},{"key":"10.7863\/jum.2012.31.3.463-BIB0023|jum2012313463-cit-0023","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/01.md.0000178976.62537.6b","article-title":"The relationship of vascular glycolipid storage to clinical manifestations of Fabry disease: a cross-sectional study of a large cohort of clinically affected heterozygous women","volume":"84","author":"Gupta","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.7863\/jum.2012.31.3.463-BIB0024|jum2012313463-cit-0024","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1023\/B:BOLI.0000028794.04349.91","article-title":"CNS involvement in Fabry disease: clinical and imaging studies before and after 12 months of enzyme replacement therapy","volume":"27","author":"Jardim","year":"2004","journal-title":"J Inherit Metab Dis"}],"container-title":["Journal of Ultrasound in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.7863%2Fjum.2012.31.3.463","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.7863\/jum.2012.31.3.463\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T03:45:08Z","timestamp":1498362308000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.7863\/jum.2012.31.3.463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"URL":"https:\/\/doi.org\/10.7863\/jum.2012.31.3.463","archive":["Portico"],"relation":{},"ISSN":["0278-4297"],"issn-type":[{"value":"0278-4297","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}